Tingkat Pengetahuan dan Sikap Masyarakat terhadap Obat Immunomodulator pada saat Pandemi COVID-19
Abstract
COVID-19 is an infectious disease caused by the most recently discovered corona virus, it was reported on May 25, 2021, there were 167,011,807 confirmed cases of COVID-19, of which there were 2,715 cases in Tasikmalaya Regency. To avoid COVID-19, many people use immunomodulatory drugs to increase their immune system. This study aims to determine how people's knowledge and attitudes towards immunomodulatory drugs are during the COVID-19 outbreak. The method used in this study is a cross sectional study, with consecutive sampling, with primary data obtained, as well as pre and post education. So that the results of this study are in the form of respondent demographics, profiles of using immunomodulators, the effect of education on public knowledge, and descriptive analysis of public knowledge with use chi square, t-test method 0.011 in the sample and control of 0.966, while the spearman test was obtained at 0.489. and spearman method. The conclusion of this study is that the level of knowledge of the people of Desa Ciawi, Kecamatan Ciawi, Kabupaten Tasikmalaya can be classified as moderate because most of the participating respondents have moderate scores during the pre-test. There is a significant relationship between education and the level of knowledge of the community about immunomodulatory drugs with a significance value of 0.011.References
Alfitasari, 2017. (2017). Aktivitas
Immunodulator Ekstrak..., Diska
Anggraeni Alfitasari, Fakultas Farmasi
UMP, 2017. 4–13.
Arjana, A. A. G., & Budiasa, K. (2016). Peran
Imunomodulator Dalam Mengaktifkan
Respon Imun Terhadap Infeksi Virus. 30.
Bloch, E. M., Shoham, S., Casadevall, A.,
Sachais, B. S., Shaz, B., Winters, J. L.,
Van Buskirk, C., Grossman, B. J.,
Joyner, M., Henderson, J. P., Pekosz, A.,
Lau, B., Wesolowski, A., Katz, L., Shan,
H., Auwaerter, P. G., Thomas, D.,
Sullivan, D. J., Paneth, N., … Tobian, A.
A. R. (2020). Deployment of
convalescent plasma for the prevention
and treatment of COVID-19. Journal of
Clinical Investigation, 130(6), 2757–
https://doi.org/10.1172/JCI138745
KEMENKES RI. (2020). Pedoman
Pencegahan dan Pengendalian
Coronavirus Disease (COVID-19).
Germas, 0–115.
https://infeksiemerging.kemkes.go.id/dow
nload/REV-04_Pedoman_P2_COVID-19__27_Maret2020_TTD1.pdf
Keputusan Menteri Kesehatan Republik
Indonesia. (2020). Keputusan Menteri
Kesehatan Republik Indonesia Nomor
HK.01.07/MenKes/413/2020 Tentang
Pedoman Pencegahan dan
Pengendalian Corona Virus Disease
(Covid-19). MenKes/413/2020,
, 207.
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020).
COVID-19: Transmission, prevention,
and potential therapeutic opportunities.
Clinica Chimica Acta, 508(May), 254–
https://doi.org/10.1016/j.cca.2020.05.044
Mukti, A. W. (2020). Hubungan Pengetahuan
terhadap Perilaku Penggunaan
Suplemen Kesehatan Warga Kebonsari
Surabaya di Masa Pandemi Covid-19.
FARMASIS: Jurnal Sains Farmasi, 1(1),
–25.
http://jurnal.unipasby.ac.id/index.php/far
masis/article/view/2656
Sambara, N.Yuliani, Bureni. (2014). Tingkat
Pengetahuan dan Pemahaman
Masyarakat Tentang Penggunaan Obat
yang Benar di Kota Kupang Tahun 2014.
Sari, R. E. P. (2010). Hubungan Antara
Tingkat Pendidikan Dengan
Pengetahuan Wanita Tentang Faktor
Resiko Kanker Payudara Di RW 02
Kompleks Taman Rempoa Indah. 3.
http://repository.uinjkt.ac.id/dspace/bitstr
eam/123456789/25639/1/RATNA EKA
PUSPITA SARI - fkik.pdf
Suherman, H. (2019). Pengaruh Faktor Usia,
Jenis Kelamin, Dan Pengetahuan
Terhadap Swamedikasi Obat. Viva
Medika: Jurnal Kesehatan, Kebidanan
Dan Keperawatan, 10(2), 94–108.
https://doi.org/10.35960/vm.v10i2.449
Susilawanti, N. L. Y. (2019). Potensi
Tumbuhan Sebagai Immunostimulan.
Farmaka, 17(2), 1–15.
WHO. (2021). WHO. (2021, May 25).
Retrieved May 25, 2021, from
Zhou, M. Y., Xie, X. L., Peng, Y. G., Wu, M. J.,
Deng, X. Z., Wu, Y., Xiong, L. J., &
Shang, L. H. (2020). From SARS to
COVID-19: What we have learned about
children infected with COVID-19.
International Journal of Infectious
Diseases,96, 710–714.